# Upbound Group, Inc.: financial statements, quarterly

UPBD · Nasdaq · CIK 933036 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/upbd.md) · [Financials](/companies/upbd/financials.md) · [Filings](/companies/upbd/filings.md) · [Insiders](/companies/upbd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/upbd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [979](/filings/0000933036-24-000181.md) | [1,018 d](/filings/0000933036-26-000008.md) | [1,096](/filings/0000933036-25-000091.md) | [1,077](/filings/0000933036-25-000146.md) | [1,069](/filings/0000933036-25-000167.md) | [1,079 d](/filings/0000933036-26-000008.md) | [1,176](/filings/0001628280-26-029049.md) | [1,158](/filings/0001193125-26-326420.md) | [1,165](/filings/0000933036-25-000167.md) | [1,196 d](/filings/0000933036-26-000008.md) | [1,220](/filings/0001628280-26-029049.md) | [1,163](/filings/0001193125-26-326420.md) |
| Cost of revenue | $m | [482](/filings/0000933036-24-000181.md) | [505 d](/filings/0000933036-26-000008.md) | [567](/filings/0000933036-25-000091.md) | [545](/filings/0000933036-25-000146.md) | [558](/filings/0000933036-25-000167.md) | [571 d](/filings/0000933036-26-000008.md) | [626](/filings/0001628280-26-029049.md) | [586](/filings/0001193125-26-326420.md) | [602](/filings/0000933036-25-000167.md) | [610 d](/filings/0000933036-26-000008.md) | [633](/filings/0001628280-26-029049.md) | [569](/filings/0001193125-26-326420.md) |
| Gross profit | $m | [497](/filings/0000933036-24-000181.md) | [513 d](/filings/0000933036-26-000008.md) | [529](/filings/0000933036-25-000091.md) | [532](/filings/0000933036-25-000146.md) | [511](/filings/0000933036-25-000167.md) | [508 d](/filings/0000933036-26-000008.md) | [550](/filings/0001628280-26-029049.md) | [572](/filings/0001193125-26-326420.md) | [563](/filings/0000933036-25-000167.md) | [587 d](/filings/0000933036-26-000008.md) | [586](/filings/0001628280-26-029049.md) | [595](/filings/0001193125-26-326420.md) |
| Operating income | $m | [58.1](/filings/0000933036-24-000181.md) | [55.9 d](/filings/0000933036-26-000008.md) | [61.8](/filings/0000933036-25-000091.md) | [80.7](/filings/0000933036-25-000146.md) | [70.1](/filings/0000933036-25-000167.md) | [79.2 d](/filings/0000933036-26-000008.md) | [62.6](/filings/0001628280-26-029049.md) | [50.7](/filings/0001193125-26-326420.md) | [52.8](/filings/0000933036-25-000167.md) | [57.2 d](/filings/0000933036-26-000008.md) | [77.4](/filings/0001628280-26-029049.md) | [54.3](/filings/0001193125-26-326420.md) |
| Interest expense | $m | [27.9](/filings/0000933036-24-000181.md) | [29.2 d](/filings/0000933036-26-000008.md) | [30.0](/filings/0000933036-25-000091.md) | [28.4](/filings/0000933036-25-000146.md) | [26.8](/filings/0000933036-25-000167.md) | [25.4 d](/filings/0000933036-26-000008.md) | [27.8](/filings/0001628280-26-029049.md) | [28.5](/filings/0001193125-26-326420.md) | [28.7](/filings/0000933036-25-000167.md) | [28.0 d](/filings/0000933036-26-000008.md) | [26.9](/filings/0001628280-26-029049.md) | [25.5](/filings/0001193125-26-326420.md) |
| Income tax | $m | [27.1](/filings/0000933036-24-000181.md) | [38.7 d](/filings/0000933036-26-000008.md) | [4.9](/filings/0000933036-25-000091.md) | [12.5](/filings/0000933036-25-000146.md) | [13.3](/filings/0000933036-25-000167.md) | [23.4 d](/filings/0000933036-26-000008.md) | [10.7](/filings/0001628280-26-029049.md) | [7.4](/filings/0001193125-26-326420.md) | [6.6](/filings/0000933036-25-000167.md) | [10.1 d](/filings/0000933036-26-000008.md) | [15.5](/filings/0001628280-26-029049.md) | [7.7](/filings/0001193125-26-326420.md) |
| Net income | $m | [4.4](/filings/0000933036-24-000181.md) | [(11.3) d](/filings/0000933036-26-000008.md) | [27.7](/filings/0000933036-25-000167.md) | [33.9](/filings/0000933036-25-000167.md) | [30.9](/filings/0000933036-25-000167.md) | [31.0 d](/filings/0000933036-26-000008.md) | [24.8](/filings/0001193125-26-326420.md) | [15.5](/filings/0001193125-26-326420.md) | [13.2](/filings/0000933036-25-000167.md) | [19.7 d](/filings/0000933036-26-000008.md) | [35.8](/filings/0001193125-26-326420.md) | [21.6](/filings/0001193125-26-326420.md) |
| Diluted EPS | $ per share | [0.08](/filings/0000933036-24-000181.md) | not reported | [0.50](/filings/0000933036-25-000091.md) | [0.61](/filings/0000933036-25-000146.md) | [0.55](/filings/0000933036-25-000167.md) | not reported | [0.42](/filings/0001628280-26-029049.md) | [0.26](/filings/0001193125-26-326420.md) | [0.22](/filings/0000933036-25-000167.md) | not reported | [0.61](/filings/0001628280-26-029049.md) | [0.37](/filings/0001193125-26-326420.md) |
| Basic EPS | $ per share | [0.08](/filings/0000933036-24-000181.md) | not reported | [0.51](/filings/0000933036-25-000091.md) | [0.62](/filings/0000933036-25-000146.md) | [0.56](/filings/0000933036-25-000167.md) | not reported | [0.44](/filings/0001628280-26-029049.md) | [0.27](/filings/0001193125-26-326420.md) | [0.23](/filings/0000933036-25-000167.md) | not reported | [0.62](/filings/0001628280-26-029049.md) | [0.37](/filings/0001193125-26-326420.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [106](/filings/0000933036-23-000174.md) | [93.7](/filings/0000933036-25-000042.md) | [84.8](/filings/0000933036-24-000101.md) | [82.5](/filings/0000933036-24-000137.md) | [85.1](/filings/0000933036-24-000181.md) | [60.9](/filings/0000933036-26-000008.md) | [107](/filings/0000933036-25-000091.md) | [107](/filings/0000933036-25-000146.md) | [107](/filings/0000933036-25-000167.md) | [121](/filings/0001193125-26-326420.md) | [98.4](/filings/0001628280-26-029049.md) | [105](/filings/0001193125-26-326420.md) |
| Total assets | $m | [2,626](/filings/0000933036-23-000174.md) | [2,721](/filings/0000933036-25-000042.md) | [2,627](/filings/0000933036-24-000101.md) | [2,620](/filings/0000933036-24-000137.md) | [2,578](/filings/0000933036-24-000181.md) | [2,650](/filings/0000933036-26-000008.md) | [3,043](/filings/0000933036-25-000091.md) | [3,095](/filings/0000933036-25-000146.md) | [3,212](/filings/0000933036-25-000167.md) | [3,276](/filings/0001193125-26-326420.md) | [3,128](/filings/0001628280-26-029049.md) | [3,104](/filings/0001193125-26-326420.md) |
| Total liabilities | $m | [2,029](/filings/0000933036-23-000174.md) | [2,161](/filings/0000933036-25-000042.md) | [2,049](/filings/0000933036-24-000101.md) | [2,024](/filings/0000933036-24-000137.md) | [1,967](/filings/0000933036-24-000181.md) | [2,021](/filings/0000933036-26-000008.md) | [2,364](/filings/0000933036-25-000091.md) | [2,410](/filings/0000933036-25-000146.md) | [2,524](/filings/0000933036-25-000167.md) | [2,580](/filings/0001193125-26-326420.md) | [2,412](/filings/0001628280-26-029049.md) | [2,370](/filings/0001193125-26-326420.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [597](/filings/0000933036-23-000174.md) | [560](/filings/0000933036-25-000042.md) | [578](/filings/0000933036-24-000101.md) | [596](/filings/0000933036-24-000137.md) | [612](/filings/0000933036-24-000181.md) | [629](/filings/0000933036-26-000008.md) | [679](/filings/0000933036-25-000091.md) | [686](/filings/0000933036-25-000146.md) | [687](/filings/0000933036-25-000167.md) | [696](/filings/0001193125-26-326420.md) | [716](/filings/0001628280-26-029049.md) | [733](/filings/0001193125-26-326420.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.0 d](/filings/0000933036-24-000181.md) | [(19.7) d](/filings/0000933036-26-000008.md) | [45.4](/filings/0000933036-25-000091.md) | [15.0 d](/filings/0000933036-25-000146.md) | [106 d](/filings/0000933036-25-000167.md) | [(61.9) d](/filings/0000933036-26-000008.md) | [148](/filings/0001628280-26-029049.md) | [26.1 d](/filings/0001193125-26-326420.md) | [89.9 d](/filings/0000933036-25-000167.md) | [41.6 d](/filings/0000933036-26-000008.md) | [171](/filings/0001628280-26-029049.md) | [123 d](/filings/0001193125-26-326420.md) |
| Capital expenditure | $m | [14.8](/filings/0000933036-24-000181.md) | [17.2 d](/filings/0000933036-26-000008.md) | [11.8](/filings/0000933036-25-000091.md) | [14.4](/filings/0000933036-25-000146.md) | [17.9](/filings/0000933036-25-000167.md) | [12.1 d](/filings/0000933036-26-000008.md) | [10.6](/filings/0001628280-26-029049.md) | [18.2](/filings/0000933036-25-000146.md) | [20.5](/filings/0000933036-25-000167.md) | [17.5 d](/filings/0000933036-26-000008.md) | [16.0](/filings/0001628280-26-029049.md) | [15.5 d](/filings/0001193125-26-326420.md) |
| Dividends paid | $m | [20.0 d](/filings/0000933036-24-000181.md) | [18.7 d](/filings/0000933036-26-000008.md) | [21.5](/filings/0000933036-25-000091.md) | [20.3 d](/filings/0000933036-25-000146.md) | [20.3 d](/filings/0000933036-25-000167.md) | [20.3 d](/filings/0000933036-26-000008.md) | [21.4](/filings/0001628280-26-029049.md) | [22.1 d](/filings/0001193125-26-326420.md) | [22.2 d](/filings/0000933036-25-000167.md) | [22.2 d](/filings/0000933036-26-000008.md) | [23.1](/filings/0001628280-26-029049.md) | [22.9 d](/filings/0001193125-26-326420.md) |
| Share repurchases | $m | not reported | [26.0 d](/filings/0000933036-26-000008.md) | not reported | not reported | not reported | [0.0 d](/filings/0000933036-26-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.4](/filings/0000933036-23-000174.md) | [56.4](/filings/0000933036-24-000101.md) | [55.2](/filings/0000933036-24-000137.md) | [56.9](/filings/0000933036-24-000181.md) | [55.8](/filings/0000933036-25-000091.md) | [55.8](/filings/0000933036-25-000146.md) | [56.0](/filings/0000933036-25-000167.md) | [58.4](/filings/0001628280-26-029049.md) | [58.7](/filings/0001193125-26-326420.md) | [58.9](/filings/0000933036-25-000167.md) | [58.8](/filings/0001628280-26-029049.md) | [58.7](/filings/0001193125-26-326420.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,299,405 at 2026-07-23, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-326420.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.